Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Jesper Falkesgaard Højen et al.|Clinical Infectious Diseases|2017Cited by 146
Development and implementation of natural killer cell simultaneous ADCC and direct killing assayMaia M. C. Bennett-Boehm, Paul W. Denton|Heliyon|2023Cited by 2